Antibody

135개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved135 programs
AntibodyLimited DatastaleBayerPhase 2

anetumab ravtansine (anetumab ravtansine)

Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#monoclonal-antibody#FallopianTubeEndometrioidAdenoca+2
Trials 14Status Discontinued
AntibodyLimited DatastaleHoffmann-La RochePhase 2

Selicrelumab (Selicrelumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#monoclonal-antibody#Hoffmann-La
Trials 13Status Recruiting
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated favezelimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#UrothelialNeoplasms+1
Trials 6Status Recruiting
AntibodyLimited DatastaleRochePhase 3

pertuzumab (Perjeta, pertuzumab [Perjeta])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase3#monoclonal-antibody#BreastCancer+1
Trials 3Status Active
AntibodyLimited DatastaleGenmabPhase 2

Acasunlimab (Acasunlimab)

Non Small Cell Lung Cancer Metastatic · Non Small Cell Lung Cancer Metastatic

#NonSmallCellLungCancerMetastatic#Antibody#Phase2#monoclonal-antibody#Genmab
Trials 2Status Recruiting
AntibodyLimited DatastaleDwight OwenPhase 1

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma

#MetastaticLungNon-SmallCellCarci#Antibody#Phase1#monoclonal-antibody#RecurrentLungNon-SmallCellCarcin+1
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 3

China-approved Bevacizumab (China-approved Bevacizumab)

Metastatic Colorectal Cancer (CRC) · Advanced Non-squamous Non-small-cell Lun

#AdvancedNon-squamousNon-small-ce#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancerCRC+1
Trials 2Status Active
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated vibostolimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#UrothelialNeoplasms+1
Trials 2Status Recruiting
AntibodyLimited DatastalePeking UniversityPhase 2

Dexamethasone, azacytidine, Pegaspargase, Tislelizumab (Dexamethasone, azacytidine, Pegaspargase, Tislelizumab)

NK/T Cell Lymphoma · NK/T Cell Lymphoma

#NKTCellLymphoma#Antibody#Phase2#monoclonal-antibody#NK+2
Trials 2Status Active
AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting
AntibodyLimited DatastaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#monoclonal-antibody#ProstateCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedBreastCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleBristol-Myers SquibbPhase 3

Abatacept (ABA, Abatacept, Abatacept (ABA) + Methotrexate (MTX), double-blind (DB))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Bristol-Myers
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Active bevacizumab and Active dexamethasone (Active bevacizumab and Active dexamethasone)

Non-Ischemic Central Retinal Vein Occlusion · Non-Ischemic Central Retinal Vein Occlus

#Non-IschemicCentralRetinalVeinOc#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 2

Adebrelimab + Cetuximab+ Chemotherapy (Adebrelimab + Cetuximab+ Chemotherapy)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleShanghai Celfuture Biotech Co.,…Phase 2

Ametumumab (Ametumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleJanssenPhase 2

Amivantamab and Recombinant Human Hyaluronidase (Amivantamab and Recombinant Human Hyaluronidase)

Locally Recurrent Skin Squamous Cell Carcinoma; Metastatic Skin Squamous Cell Carcinoma · Locally Recurrent Skin Squamous Cell Car

#LocallyRecurrentSkinSquamousCell#Antibody#Phase2#monoclonal-antibody#MetastaticSkinSquamousCellCarcin+1
Trials 1Status Discontinued
AntibodyLimited DatastaleGustave Roussy, Cancer Campus, …Phase 2

atezolizumab (Tecentriq, Anti-PD-L1 antibody atezolizumab)

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma ) · PD-L1

#PD-L1#Antibody#Phase2#monoclonal-antibody#PatientsWithMetastaticTumoursCol+3
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab + Ipatasertib)

Gastric Adenocarcinoma; Metastatic Gastric Cancer · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#MetastaticGastricCancer+1
Trials 1Status Active

2 / 7 pages

← PreviousNext →